Anixa Biosciences Inc (ANIX) › Capital ExpendituresAnixa Biosciences Inc (ANIX) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2010: $2.1K2011: $9.0K2012: $1.6K2014: $6.7K2015: $54.8K2016: $146.5K2017: $30.2K2018: $38.4K2019: $175.5K2020: $15.8K$15.8K2010Capital Expenditures (USD)2020Fiscal YearCapital ExpendituresChange YoY2020$15.8K-91.0%2019$175.5K+356.9%2018$38.4K+27.2%2017$30.2K-79.4%2016$146.5K+167.5%2015$54.8K+719.5%2014$6.7K—2012$1.6K-82.3%2011$9.0K+336.3%2010$2.1K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share